Sponsor:
University of Kansas Medical Center
Code:
NCT04808596
Conditions
Pulmonary Hypertension
Pulmonary Arterial Hypertension
Pulmonary Hypertension Due to Left Heart Disease
Pulmonary Hypertension, Primary
Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Brief summary:
Conditions
Pulmonary Hypertension
Pulmonary Arterial Hypertension
Pulmonary Hypertension Due to Left Heart Disease
Pulmonary Hypertension, Primary
Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Study ID
NCT04808596
Start date
Aug 10, 2020
Status verified date
Jul, 2025
Completion date
Jul 31, 2027
Anticipated
Primary completion date
Dec 31, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
300 participants
Anticipated
Primary outcome measure
Central contacts
Kimberly Cygan, MBA, BSN, RN
kcygan@kumc.eduLocations
University of Kansas Medical Center
Recruiting
Kansas City, Kansas, United States, 66160
Contacts
Kimberly Cygan, MBA, BSN, RN
kcygan@kumc.eduPrincipal Investigator:
Leslie A Spikes, MD
Sponsor
University of Kansas Medical Center
Last update posted
Aug 1, 2025
Last verified
Jul, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-25. This information was provided to ClinicalTrials.gov by University of Kansas Medical Center on 2025-08-01. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.